0 CHECKOUT

PRODUCT FILTERS

REGION

68
13
11
11
8

COUNTRY

11
5
2
2
1

CATEGORIES

  • 24
  • 24
  • 23
  • 10
  • 9
  • 8
  • 7
  • 7
  • 6
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

6
10
24
120

PUBLISHED

0
4
22
120

PRODUCT TYPE

111
4
4
1

Search for: "Breast Cancer Drug Futures 2010"

120 Products

Global Breast Cancer Market 2014-2018

About Breast Cancer Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically,...

Published:  June 2014
Price:  From

The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth

The report titled "The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth" provides a comprehensive analysis on the Anti Cancer Drug market in the US covering various...

Published:  July 2014
Price:  From

Breast Cancer Therapies Markets

Breast cancer therapies are entering a new era as game-changers emerge for each of the major breast cancer patient populations New market entrants must possess drug profiles and a savvy clinical development...

Published:  November 2012
Price:  From

Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth

The current market for breast cancer consists of five monoclonal Antibodies (mAbs), three of which are targeted at the Human Epidermal growth factor Receptor 2 (HER-2) protein Four are aimed at improving...

Published:  October 2013
Price:  From

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer...

Published:  September 2014
Price:  From

Global & USA Cancer Immunotherapy Market Analysis to 2020

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR)...

Published:  April 2015
Price:  From

Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players

GBI Research, the leading business intelligence provider, has released its latest research, ""Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars...

Published:  April 2013
Price:  From

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women...

Published:  January 2015
Price:  From

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

Published:  October 2011
Price:  From

US Cancer Vaccine Market Outlook 2018

Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments Therapeutic cancer vaccines and Prophylactic cancer vaccines are the...

Published:  February 2014
Price:  From

Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion

GBI Research, the leading business intelligence provider, has released its latest research, “Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue...

Published:  April 2012
Price:  From

Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth

Gastric and esophageal cancers are two orphan cancers of the gastrointestinal tract They are often diagnosed at advanced, incurable stages due to a late onset of symptoms, but are also associated with...

Published:  December 2013
Price:  From

Circulating Tumor Cells and Cancer Stem Cells Technologies - Global Strategic Business Report

This report analyzes the worldwide markets for Circulating Tumor Cells and Cancer Stem Cells Technologies in US$ Million The report provides separate comprehensive analytics for the US, Canada, Japan,...

Published:  March 2014
Price:  From
Circulating Tumor Cells and Cancer Stem Cells Technologies - Global Strategic Business Report Circulating Tumor Cells and Cancer Stem Cells Technologies - Global Strategic Business Report - Product Thumbnail Image

Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends and Pipeline Analysis)

“GLOBAL & USA CANCER BIOMARKER MARKET to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-development, Business Strategies, Industry Trends, and Pipeline...

Published:  May 2014
Price:  From

Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake

GBI Research, the leading business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival,...

Published:  March 2013
Price:  From

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Exceptionally Large and Innovative Pipeline: The breast cancer pipeline is the largest in the pharmaceutical industry with 815 products in active development across all stages. The range of mechanisms...

Published:  July 2014
Price:  From

Cancer Monoclonal Antibodies Market Forecast to 2017

Cancer, one of the leading causes of death worldwide, affected approximately 13 Million people in 2012 and this figure is expected to grow to 17 Million by 2020 The dramatic increase in the size of...

Published:  August 2013
Price:  From

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

Published:  July 2014
Price:  From

Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market

Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market Summary GBI Research, the leading business intelligence...

Published:  January 2011
Price:  From

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

Published:  March 2015
Price:  From
Loading Indicator

Our Clients

  • Intel Corporation
  • Autodesk, Inc.
  • Hewlett-Packard Company
  • Ahlstrom Corporation
  • SAP SE
  • 3M Company
  • Samsung Group Ltd.